Neurofibroma classification: Difference between revisions

	Neurofibroma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Neurofibroma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Neurofibroma classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Neurofibroma classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Neurofibroma classification
CDC on Neurofibroma classification
Neurofibroma classification in the news
Blogs on Neurofibroma classification
Directions to Hospitals Treating Neurofibroma
Risk calculators and risk factors for Neurofibroma classification

VisualWikitext

Revision as of 19:35, 13 November 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

Neurofibroma may be classified into 2 subtypes: dermal neurofibroma and plexiform neurofibroma.

Classification

Neurofibroma may be classified into 2 subtypes:^[1]

Dermal neurofibroma

Dermal neurofibromas are associated with a single peripheral nerve.

Plexiform Neurofibroma

Plexiform neurofibromas are associated with multiple nerve bundles.

References

↑ Neurofibroma. Wikipedia 2015. https://en.wikipedia.org/wiki/Neurofibroma

Template:WikiDoc Sources

[1] Neurofibroma. Wikipedia 2015. https://en.wikipedia.org/wiki/Neurofibroma

[1]

@@ Line 3: / Line 3: @@
 {{CMG}}; {{AE}} {{SC}}
 ==Overview==
+Neurofibroma may be classified into 2 subtypes: dermal neurofibroma and plexiform neurofibroma.
 ==Classification==
-Neurofibromas have been subdivided into two broad categories: dermal and plexiform.  Dermal neurofibromas are associated with a single peripheral nerve, while plexiform neurofibromas are associated with multiple nerve bundles.  According to the World Health Organization classification system, dermal and plexiform neurofibromas are [[Grading (tumors)|grade I]] tumors.  Plexiform neurofibroma are more difficult to treat and can transform into malignant tumors.  Dermal neurofibroma do not become malignant.
+Neurofibroma may be classified into 2 subtypes:<ref>Neurofibroma. Wikipedia 2015. https://en.wikipedia.org/wiki/Neurofibroma</ref>
+* Dermal neurofibroma
-===Dermal neurofibroma===
+:* Dermal neurofibromas are associated with a single peripheral nerve.
+* Plexiform Neurofibroma
-===Plexiform Neurofibroma===
+:* Plexiform neurofibromas are associated with multiple nerve bundles.
-About 10% of plexiform neurofibromas undergo transformation into a [[malignant peripheral nerve sheath tumor]] (MPNST).<ref name="pmid12898075">{{cite journal |author=Mautner VF, Friedrich RE, von Deimling A, Hagel C, Korf B, Knöfel MT, Wenzel R, Fünsterer C. |title=Malignant peripheral nerve sheath tumours in neurofibromatosis type 1: MRI supports the diagnosis of malignant plexiform neurofibroma. |journal=American Journal of Pathology |volume=45 |issue=9 |pages=618–25 |year=2003 |pmid=12898075 |doi=10.1007/s00234-003-0964-6}}</ref>  The formation of malignant cancers from neurofibromas is associated with the loss of expression of the [[P16 (gene)|CDKN2A]] or [[TP53]] gene in non-myelinating Schwann cells that also exhibit biallelic inactivation of the NF1 gene.
 ==References==

Neurofibroma classification: Difference between revisions

Revision as of 19:35, 13 November 2015

Overview

Classification

References

Navigation menu